Retatrutide 30mg
Retatrutide 30mg is listed by Revitalis Science as a research compound for laboratory research use only. This page provides product presentation context, links to quality information and the external Square checkout path used for ordering.
Research Format Summary
Product name: Retatrutide 30mg
Format shown: 30mg
Checkout path: secure external Square link from this page.
Before Ordering
Researchers can review the product page, quality information and related policy pages before proceeding to checkout.
Compound Background
Full name: Retatrutide.
Research format listed by Revitalis Science: 30mg.
Molecular / structural summary: investigational peptide research compound described in public databases as a single-molecule agonist of the GIP, GLP-1 and glucagon receptors. Formula reference: C221H342N46O68.
Research and development context: Retatrutide was developed by Eli Lilly for metabolic-disease research programs, including obesity and type 2 diabetes investigation. This site presents it only as a laboratory research compound, not as a medicine or treatment.
Reference context: PubChem compound record · Lilly research overview
Related Quality Information
Supporting documentation context and laboratory acknowledgement material are available on the dedicated quality page.
Important Notice
All products on this website are supplied strictly for laboratory research purposes only. They are not for human or veterinary use.
No therapeutic, diagnostic, cosmetic, performance or medical claims are made.
Customer Feedback
A. R.: Smooth checkout, clear research labelling and fast shipping. Everything arrived well packaged and easy to organise.
Feedback is presented as service feedback only and relates to checkout, dispatch, packaging and labelling. It is not a product-effect statement.